1-196779312-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021023.6(CFHR3):āc.209T>Cā(p.Ile70Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000817 in 1,529,400 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000037 ( 2 hom., cov: 25)
Exomes š: 0.000086 ( 23 hom. )
Consequence
CFHR3
NM_021023.6 missense
NM_021023.6 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 3.33
Genes affected
CFHR3 (HGNC:16980): (complement factor H related 3) The protein encoded by this gene is a secreted protein, which belongs to the complement factor H-related protein family. It binds to heparin, and may be involved in complement regulation. Mutations in this gene are associated with decreased risk of age-related macular degeneration, and with an increased risk of atypical hemolytic-uremic syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.1973246).
BS2
High Homozygotes in GnomAd4 at 2 AD,AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR3 | NM_021023.6 | c.209T>C | p.Ile70Thr | missense_variant | 2/6 | ENST00000367425.9 | |
CFHR3 | NM_001166624.2 | c.209T>C | p.Ile70Thr | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR3 | ENST00000367425.9 | c.209T>C | p.Ile70Thr | missense_variant | 2/6 | 1 | NM_021023.6 | P1 | |
CFHR3 | ENST00000471440.6 | c.209T>C | p.Ile70Thr | missense_variant | 2/5 | 1 | |||
CFHR3 | ENST00000391985.7 | c.209T>C | p.Ile70Thr | missense_variant | 2/5 | 2 | |||
CFHR3 | ENST00000367427.7 | c.209T>C | p.Ile70Thr | missense_variant, NMD_transcript_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000366 AC: 5AN: 136622Hom.: 2 Cov.: 25
GnomAD3 genomes
AF:
AC:
5
AN:
136622
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000629 AC: 15AN: 238384Hom.: 4 AF XY: 0.0000700 AC XY: 9AN XY: 128542
GnomAD3 exomes
AF:
AC:
15
AN:
238384
Hom.:
AF XY:
AC XY:
9
AN XY:
128542
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000862 AC: 120AN: 1392656Hom.: 23 Cov.: 30 AF XY: 0.0000867 AC XY: 60AN XY: 691658
GnomAD4 exome
AF:
AC:
120
AN:
1392656
Hom.:
Cov.:
30
AF XY:
AC XY:
60
AN XY:
691658
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000366 AC: 5AN: 136744Hom.: 2 Cov.: 25 AF XY: 0.0000451 AC XY: 3AN XY: 66584
GnomAD4 genome
AF:
AC:
5
AN:
136744
Hom.:
Cov.:
25
AF XY:
AC XY:
3
AN XY:
66584
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
10
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.209T>C (p.I70T) alteration is located in exon 2 (coding exon 2) of the CFHR3 gene. This alteration results from a T to C substitution at nucleotide position 209, causing the isoleucine (I) at amino acid position 70 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;.;T;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M;.
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;.
REVEL
Benign
Sift
Uncertain
D;D;D;.
Sift4G
Uncertain
D;D;D;D
Polyphen
D;D;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at